NASDAQ:NEOG - Neogen Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$80.71 -1.30 (-1.59 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$82.01
Today's Range$80.10 - $82.69
52-Week Range$47.67 - $84.46
Volume264,200 shs
Average Volume193,161 shs
Market Capitalization$4.23 billion
P/E Ratio95.36
Dividend YieldN/A
Beta1.3
Neogen logoNeogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Debt-to-Equity RatioN/A
Current Ratio9.44
Quick Ratio7.37

Price-To-Earnings

Trailing P/E Ratio95.36
Forward P/E Ratio68.40
P/E Growth4.32

Sales & Book Value

Annual Sales$361.59 million
Price / Sales11.51
Cash Flow$1.1325 per share
Price / Cash71.27
Book Value$9.28 per share
Price / Book8.70

Profitability

EPS (Most Recent Fiscal Year)$0.86
Net Income$43.79 million
Net Margins14.82%
Return on Equity11.49%
Return on Assets10.31%

Miscellaneous

Employees1,413
Outstanding Shares51,580,000
Market Cap$4,230.32

The Truth About Cryptocurrencies

Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were distributed to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) released its quarterly earnings results on Tuesday, July, 19th. The company reported $0.20 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.20. The firm earned $90.10 million during the quarter, compared to the consensus estimate of $86.27 million. Neogen had a return on equity of 11.49% and a net margin of 14.82%. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Tuesday, July, 17th 2018. View Earnings Estimates for Neogen.

What price target have analysts set for NEOG?

3 brokerages have issued 12-month target prices for Neogen's shares. Their forecasts range from $60.00 to $65.00. On average, they anticipate Neogen's stock price to reach $62.3333 in the next twelve months. This suggests that the stock has a possible downside of 22.8%. View Analyst Ratings for Neogen.

What is the consensus analysts' recommendation for Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Neogen's key competitors?

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 78)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 56)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 53)
  • Mr. John Edward Adent, CEO & Pres (Age 50)
  • Mr. Rod Poland, Director of Corp. Communications

Has Neogen been receiving favorable news coverage?

News articles about NEOG stock have been trending somewhat positive recently, according to Accern. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neogen earned a media sentiment score of 0.09 on Accern's scale. They also assigned media stories about the company an impact score of 45.62 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Neogen's major shareholders?

Neogen's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.89%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, Richard E Calk, Jr, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which institutional investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC. Company insiders that have sold Neogen company stock in the last year include Edward Bradley, G Bruce Papesh, James L Herbert, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Insider Buying and Selling for Neogen.

Which institutional investors are buying Neogen stock?

NEOG stock was purchased by a variety of institutional investors in the last quarter, including Xact Kapitalforvaltning AB. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $80.71.

How big of a company is Neogen?

Neogen has a market capitalization of $4.23 billion and generates $361.59 million in revenue each year. The company earns $43.79 million in net income (profit) each year or $0.86 on an earnings per share basis. Neogen employs 1,413 workers across the globe.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]


MarketBeat Community Rating for Neogen (NASDAQ NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  206 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  486
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.